The Government has announced new restrictions on the export of flu vaccine supplies, following a ‘global spike’ in demand.
The Department of Health and Social Care (DHSC) said the restrictions will ‘stop the exporting of medicines placed on the market to be used in the UK, which could cause future supply issues’.
The restrictions have been introduced in response to high demand for the flu vaccine from other countries, DHSC said, and will apply to the flu vaccines being used in the UK this winter.
It added that there remains ‘sufficient national supply of flu vaccine in the UK, with ‘deliveries to providers continuing over the coming months’.
Health secretary Matt Hancock said: ‘This action will protect our supply of flu vaccinations, as part of our plans to give 30 million the flu vaccine ahead of this unprecedented winter.’
In addition to the Influenza vaccine, Anakinra has been added to the existing list of medicines restricted for export and hoarding.
Companies that export a medicine that is on the export restrictions list may face regulatory action from the Medicines and Healthcare products Regulatory Agency (MHRA), DHSC said.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.